Oncotarget

Vol 9, No 100

December 21, 2018

View Archive »

Order a Reprint

About The Cover

The cover for issue 100 of Oncotarget features Figure 9, "Proposed model for the induction of PD-L1 by Hh signaling," by Chakrabarti, et al.

Table of Contents

Editorial

Intermediate phenotypes underlying osteosarcoma risk

Intermediate phenotypes underlying osteosarcoma risk

https://doi.org/10.18632/oncotarget.26476

Eleanor C. Semmes, Chenan Zhang,  and Kyle M. Walsh
37345-37346
PDF  |  Order a Reprint

UBE2N plays a pivotal role in maintaining melanoma malignancy

UBE2N plays a pivotal role in maintaining melanoma malignancy

https://doi.org/10.18632/oncotarget.26482

Anushka Dikshit,  and Jennifer Y. Zhang
37347-37348
PDF  |  Order a Reprint

Targeting hyaluronan accumulation in the tumor microenvironment

Targeting hyaluronan accumulation in the tumor microenvironment

https://doi.org/10.18632/oncotarget.26483

Xiaoming Li,  and Curtis B. Thompson
37349-37351
PDF  |  Order a Reprint

Priority Research Papers

CDK4/6 inhibition stabilizes disease in patients with p16-null non-small cell lung cancer and is synergistic with mTOR inhibition

CDK4/6 inhibition stabilizes disease in patients with p16-null non-small cell lung cancer and is synergistic with mTOR inhibition

https://doi.org/10.18632/oncotarget.26424

Priya K. Gopalan, Andres Gordillo Villegas, Chunxia Cao, Mary Pinder-Schenck, Alberto Chiappori, Wei Hou, Maria Zajac-Kaye, Alison M. Ivey,  and Frederic J. Kaye
37352-37366
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Research Papers

Anti-claudin-4 extracellular domain antibody enhances the antitumoral effects of chemotherapeutic and antibody drugs in colorectal cancer

Anti-claudin-4 extracellular domain antibody enhances the antitumoral effects of chemotherapeutic and antibody drugs in colorectal cancer

https://doi.org/10.18632/oncotarget.26427

Rina Fujiwara-Tani, Takamitsu Sasaki, Yi Luo, Kei Goto, Isao Kawahara, Yukiko Nishiguchi, Shingo Kishi, Shiori Mori, Hitoshi Ohmori, Masuo Kondoh,  and Hiroki Kuniyasu
37367-37378
Abstract  |  PDF  |  HTML  |  Order a Reprint

MEK-inhibitor PD184352 enhances the radiosensitizing effect of the Hsp90 inhibitor NVP-AUY922: the role of cell type and drug-irradiation schedule

MEK-inhibitor PD184352 enhances the radiosensitizing effect of the Hsp90 inhibitor NVP-AUY922: the role of cell type and drug-irradiation schedule

https://doi.org/10.18632/oncotarget.26436

Felix Grabenbauer, Astrid Katzer, Dmitri Sisario, Simon Memmel, Michael Flentje, Vladimir L. Sukhoruko,  and Cholpon S. Djuzenova
37379-37392
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

EGFR C797S, EGFR T790M and EGFR sensitizing mutations in non-small cell lung cancer revealed by six-color crystal digital PCR

EGFR C797S, EGFR T790M and EGFR sensitizing mutations in non-small cell lung cancer revealed by six-color crystal digital PCR

https://doi.org/10.18632/oncotarget.26446

Jordan Madic, Cécile Jovelet, Julien Lopez, Barbara André, Jean Fatien, Isabelle Miran, Aurélie Honoré, Laura Mezquita, Benjamin Besse, Ludovic Lacroix,  and Magali Droniou
37393-37406
Abstract  |  PDF  |  HTML  |  Order a Reprint

Identification of a gene signature for different stages of breast cancer development that could be used for early diagnosis and specific therapy

Identification of a gene signature for different stages of breast cancer development that could be used for early diagnosis and specific therapy

https://doi.org/10.18632/oncotarget.26448

Charu Kothari, Geneviève Ouellette, Yvan Labrie, Simon Jacob, Caroline Diorio,  and Francine Durocher
37407-37420
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Anti-C1-inactivator treatment of glioblastoma

Anti-C1-inactivator treatment of glioblastoma

https://doi.org/10.18632/oncotarget.26456

Karolina Förnvik, Jonatan Ahlstedt, Kurt Osther, Leif G. Salford,  and Henrietta Nittby Redebrandt
37421-37428
Abstract  |  PDF  |  HTML  |  Order a Reprint

KLHL5 knockdown increases cellular sensitivity to anticancer drugs

KLHL5 knockdown increases cellular sensitivity to anticancer drugs

https://doi.org/10.18632/oncotarget.26462

Robert J. Schleifer, Shuchun Li, Wyatt Nechtman, Eric Miller, Shan Bai, Ashok Sharma,  and Jin-Xiong She
37429-37438
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Hedgehog signaling induces PD-L1 expression and tumor cell proliferation in gastric cancer

Hedgehog signaling induces PD-L1 expression and tumor cell proliferation in gastric cancer

https://doi.org/10.18632/oncotarget.26473

Jayati Chakrabarti, Loryn Holokai, LiJyun Syu, Nina G. Steele, Julie Chang, Jiang Wang, Syed Ahmed, Andrzej Dlugosz,  and Yana Zavros
37439-37457
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint


Copyright © 2019 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC